BiotechTube
Home/Pipeline/Digital Biomarker for COPD

Digital Biomarker for COPD

COPD

Early DevelopmentActive

Key Facts

Indication
COPD
Phase
Early Development
Status
Active
Company
electronRx

About electronRx

Digital‑biomarker platform that delivers continuous, AI‑powered insights for respiratory disease drug development.

View full company profile

Therapeutic Areas

COPDAsthmaInterstitial Lung DiseasePulmonary Hypertension

Other COPD Drugs

DrugCompanyPhase
Yupelri® (revefenacin)Cleo Life SciencesApproved
Spiro Neuromodulation SystemSpiro MedicalPhase 2
VL-PX10 & VL-P22Vitti LabsPhase 2
SolrikitugUniquity BioPhase 2
CAL-4Calyxha BiotechnologiesDiscovery
OligoG (Inhaled)AlgipharmaPhase 2
TozorakimabAstraZenecaPhase III
Eclira Genuair (Acidinium Bromide)KYORIN PharmaceuticalMarketed
ANORO ELLIPTAInnovivaCommercial
GB-0895Generate BiomedicinesPhase 1